Grant: Discovery Grants Program - Individual
Queen's University
$33,000.00
Topics in Statistical Theory and Methods for Cancer Clinical Trials
EF 2021-22
Résumé
adaptive randomization; assessment of treatment effects; biostatistics; correlated data; empirical likelihood; high-dimensional data; phase II clincal trials; resampling methods; statistical inference; survival analysis
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2016-04819
Name nom
Tu, Dongsheng
Department département
Public Health Sciences
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2016
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1508
Committee name en
Mathematics and Statistics
Committee name fr
Mathématiques et statistique
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3005
Research subject group en
Statistics and probability
Research subject group fr
Statistique et probabilité
Research subject en
Biostatistics
Research subject fr
Biostatistiques
Installment
inst:6
Partie
1
Nb partie
6
Application title
Topics in Statistical Theory and Methods for Cancer Clinical Trials
Keyword
NSERC
Application summary
adaptive randomization; assessment of treatment effects; biostatistics; correlated data; empirical likelihood; high-dimensional data; phase II clincal trials; resampling methods; statistical inference; survival analysis